https://scholars.lib.ntu.edu.tw/handle/123456789/518308
標題: | Reversal of doxorubicin resistance in breast cancer cells by photochemical internalization | 作者: | PEI-JEN LOU Lai P.-S. MING-JIUM SHIEH MacRobert A.J. Berg K. Bown S.G. |
公開日期: | 2006 | 卷: | 119 | 期: | 11 | 起(迄)頁: | 2692-2698 | 來源出版物: | International Journal of Cancer | 摘要: | Multiple drug resistance (MDR) is a problem that seriously reduces the efficacy of many chemotherapy agents. One mechanism for MDR is increased acidification of endocytic vesicles and increased cytosol pH, so weak base chemotherapeutic agents, including doxorubicin, are trapped in endocytic vesicles and exhibit a drug resistant phenotype. Treatments that selectively reverse this accumulation may therefore reverse the MDR phenotype. Photochemical internalization (PCI) is a novel technology developed for site-specific enhancement of the therapeutic efficacy of macromolecules by selective photochemical rupture of endocytic vesicles and consequent release of endocytosed macromolecules into the cytosol. This study evaluates PCI for release of doxorubicin from endocytic vesicles in MDR cells. Two breast cancer cell lines, MCF-7 and MCF-7/ADR (the latter resistant to doxorubicin), were selected. They were found equally sensitive to photochemical treatment with the photosensitiser TPPS2a (disulfonated meso-tetraphenylporphine) and light. On exposure to doxorubicin alone, the IC50 (drug concentration for 50% reduction in colony formation) was 0.1 μM for MCF-7 and 1 μM for MCF-7/ADR. After PCI (photochemical treatment followed by doxorubicin), the IC50 concentration was 0.1 μM for both cell lines. Comparable changes were seen with assay of cell viability using 3-(4,5-dimethyltiazol-2-yl) -2,5-diphenyltetrazolium bromide (MTT). On fluorescence microscopy in MCF-7/ADR cells, doxorubicin localised in granules identified as lysosomes. After PCI, doxorubicin was released into the cytosol and entered cell nuclei, as was seen in MCF-7 cells without PCI. In conclusion, PCI reversed the MDR phenotype of doxorubicin resistant breast cancer cells by endolysosomal release of the drug. The technique is a promising new approach to tackling the problem of MDR. ? 2000 Wiley-Liss, Inc. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-33750720278&doi=10.1002%2fijc.22098&partnerID=40&md5=59fadcb7ac6248ddb2026418cbcbb9ce https://scholars.lib.ntu.edu.tw/handle/123456789/518308 |
ISSN: | 0020-7136 | DOI: | 10.1002/ijc.22098 | SDG/關鍵字: | 3 (4,5 dimethyl 2 thiazolyl) 2,5 diphenyltetrazolium bromide; doxorubicin; photosensitizing agent; tetraphenylporphinesulfonic acid; acidification; article; breast cancer; cancer localization; cancer resistance; cell nucleus; controlled study; drug release; endosome; fluorescence microscopy; human; human cell; IC 50; macromolecule; multidrug resistance; phenotype; photochemical internalization; photochemotherapy; photodynamic therapy; photosensitization; priority journal; technology; Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Microscopy, Confocal; Microscopy, Fluorescence; Photochemistry |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。